
UnitedHealth Group (UNH) Stock Forecast & Price Target
UnitedHealth Group (UNH) Analyst Ratings
Bulls say
UnitedHealth Group’s strong position in the healthcare insurance sector is underscored by its anticipated 800,000 member growth in Medicare Advantage, translating to a 10% year-over-year enrollment increase, indicative of robust demand for its plans. The company has demonstrated effective cost controls with a shift towards HMO growth, which aligns with management's positive outlook on enrollment dynamics and margin improvements amidst a competitive landscape. Furthermore, the revised margin forecasts for OptumInsight, alongside expected EPS growth of 13-16% by 2026, suggest a potential for financial performance to revert to historical multiples, enhancing the overall investment thesis for UnitedHealth Group.
Bears say
UnitedHealth Group has experienced a sequential decline in Optum Health consumers, falling from 104 million to 100 million, raising concerns about its growth trajectory. Despite reporting a 4Q EPS of $6.81, which surpassed expectations, the company faced a significant MLR miss of 87.6% and a margin shortfall in OptumHealth, leading to a downward revision of its 2025 margin forecast by 20 basis points. The company's outlook is further challenged by anticipated pressures from cost trends in 2024, competitive government program dynamics, and various regulatory risks which could hinder profitability and market performance.
This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.
UnitedHealth Group (UNH) Analyst Forecast & Price Prediction
Start investing in UnitedHealth Group (UNH)
Order type
Buy in
Order amount
Est. shares
0 shares